A2 Biotherapeutics in Agoura Hills closed its Series B round of financing at $71.5 million, the biotech company announced on Tuesday, bringing the total amount raised to $136 million since its inception in 2018. ...

Subscribe to get the full story.


Are you a subscriber? Sign In